Atomoxetine Hydrochloride Patent Expiration
Atomoxetine Hydrochloride is Used for managing symptoms of attention-deficit hyperactivity disorder. It was first introduced by Eli Lilly And Co
Atomoxetine Hydrochloride Patents
Given below is the list of patents protecting Atomoxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Strattera |
US5658590 (Pediatric) | Treatment of attention-deficit/hyperactivity disorder |
May 26, 2017
(Expired) | Lilly |
Strattera | US5658590 | Treatment of attention-deficit/hyperactivity disorder |
Nov 26, 2016
(Expired) | Lilly |
Atomoxetine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Atomoxetine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Atomoxetine Hydrochloride. The first generic version for Atomoxetine Hydrochloride was by Zydus Pharmaceuticals Usa Inc and was approved on Sep 16, 2010. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Apr 5, 2023.
Given below is the list of companies who have filed for Atomoxetine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||
Canada |
| |||||||||||||
India |
|
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 18MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 10MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | Feb 23, 2018 |
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
5. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 25MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 10MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2021 |
6. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 10MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | Feb 18, 2021 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
India |
|
7. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 10MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 18MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | May 30, 2017 |
8. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 18MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 25MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 100MG BASE | capsule | Prescription | ORAL | AB | Sep 16, 2010 |
EQ 10MG BASE | capsule | Prescription | ORAL | AB | Apr 5, 2023 |